Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
VTP-1000 by Barinthus Biotherapeutics for Celiac Disease: Likelihood of Approval
VTP-1000 is under clinical development by Barinthus Biotherapeutics and currently in Phase I for Celiac Disease. According to GlobalData, Phase...